{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Shocked by the rapid adoption of a new $84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren&#8217;t blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.", "headline": {"main": "Insurers Scrutinize Drug Costs After $84,000 Sovaldi Surprise", "print_headline": "Insurers Scrutinize Drug Costs After $84,000 Sovaldi Surprise"}, "abstract": null, "print_page": null, "word_count": "1329", "_id": "53859eea7988103dac135daf", "snippet": "Shocked by the rapid adoption of a new $84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren&#8217;t blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/05/28/us/28reuters-usa-healthcare-hepatitisc-insight.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-05-28T04:30:23Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Speaking Up About an Uncomfortable Condition ", "kicker": "Well", "print_headline": "Speaking Up About an Uncomfortable Condition "}, "abstract": "With more awareness about the risk factors of inflammatory bowel diseases like Crohn\u2019s and ulcerative colitis, those with a genetic predisposition can take precautions.", "print_page": null, "word_count": "1018", "_id": "5382bcaa7988104f45ed7a53", "snippet": "With more awareness about the risk factors of inflammatory bowel diseases like Crohn\u2019s and ulcerative colitis, those with a genetic predisposition can take precautions.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/05/26/speaking-up-about-an-uncomfortable-condition/", "multimedia": [{"subtype": "wide", "url": "images/2014/05/27/science/27BROD/27BROD-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/27/science/27BROD/27BROD-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/27/science/27BROD/27BROD-articleLarge.jpg", "height": 481, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/27/science/27BROD/27BROD-articleLarge.jpg", "xlargeheight": "481"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/27/science/27BROD/27BROD-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/27/science/27BROD/27BROD-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Digestive Tract", "name": "subject", "rank": "3"}, {"value": "Crohn's Disease", "name": "subject", "rank": "2"}, {"value": "Medicine and Health", "name": "subject", "rank": "4"}, {"value": "Colon", "name": "subject", "rank": "1"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "blogpost", "pub_date": "2014-05-26T00:01:03Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "With a sweeping new policy for medical marijuana, Canada is aiming for a market of large-scale \u2014 and highly regulated \u2014 growers.", "headline": {"main": "When Cannabis Goes Corporate", "print_headline": "When Cannabis Goes Corporate"}, "abstract": "Canada has rolled out a sweeping new policy that has created an extensive, heavily regulated system for growing and selling marijuana; law requires users with prescriptions to buy from a short list of approved, large-scale, profit-seeking producers; requirements are giving rise to what many think will be a lucrative new industry, with some estimating influx of 3.1 billion Canadian dollars a year in sales within next decade.", "print_page": "1", "word_count": "2674", "_id": "5380c6807988101ee82c9a39", "snippet": "With a sweeping new policy for medical marijuana, Canada is aiming for a market of large-scale \u2014 and highly regulated \u2014 growers.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/25/business/international/when-cannabis-goes-corporate.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/25/business/25-POT-JP1/25-POT-JP1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/25/business/25-POT-JP1/25-POT-JP1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/25/business/25-POT-JP1/25-POT-JP1-articleLarge.jpg", "height": 293, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/25/business/25-POT-JP1/25-POT-JP1-articleLarge.jpg", "xlargeheight": "293"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/25/business/25-POT/25-POT-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/25/business/25-POT/25-POT-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "International Business", "keywords": [{"value": "Labor and Jobs", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Tweed Marijuana", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Marijuana", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Canada", "is_major": "Y", "rank": "3", "name": "glocations"}, {"value": "Law and Legislation", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Tilray/Lafitte Ventures Ltd", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Medical Marijuana", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Smiths Falls (Ontario)", "is_major": "N", "rank": "9", "name": "glocations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Ian", "lastname": "AUSTEN"}], "original": "By IAN AUSTEN"}, "document_type": "article", "pub_date": "2014-05-25T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Review", "blog": [], "news_desk": "BookReview", "lead_paragraph": "A 40-something rock singer looks to revive a career she had long abandoned.", "headline": {"seo": "\u2018Wonderland,\u2019 by Stacey D\u2019Erasmo", "main": "On the Road Again", "print_headline": "On the Road Again"}, "abstract": "Lionel Shriver reviews book Wonderland by Stacey D'Erasmo.", "print_page": null, "word_count": "1204", "_id": "537f5ae379881021c85e091f", "snippet": "A 40-something rock singer looks to revive a career she had long abandoned.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/25/books/review/wonderland-by-stacey-derasmo.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-articleLarge.jpg", "height": 639, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-articleLarge.jpg", "xlargeheight": "639"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/25/books/review/0525-bks-Shriver/0525-bks-Shriver-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Sunday Book Review", "keywords": [{"value": "Books and Literature", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "D'Erasmo, Stacey", "is_major": "Y", "rank": "2", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Lionel", "lastname": "SHRIVER"}], "original": "By LIONEL SHRIVER"}, "document_type": "article", "pub_date": "2014-05-25T00:00:00Z", "section_name": "Books"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Welcome to the brave new world of bioelectronics: implants that can communicate directly with the nervous system in order to try to fight everything from cancer to the common cold.", "headline": {"main": "Can the Nervous System Be Hacked?", "print_headline": "Invasion of the Body Hackers"}, "abstract": "Michael Behar article examines growing field of bioelectronics, in which implants are thought to be able to communicate directly with the nervous system in order to try to fight wide variety of diseases; notes that GlaxoSmithKline runs newly formed Bioelectronics R & D Unit, which has partnerships with 26 independent research groups in six countries.", "print_page": "36", "word_count": "5281", "_id": "537f5a1379881021c85e0919", "snippet": "Welcome to the brave new world of bioelectronics: implants that can communicate directly with the nervous system in order to try to fight everything from cancer to the common cold.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/25/magazine/can-the-nervous-system-be-hacked.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-articleLarge.jpg", "height": 765, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-articleLarge.jpg", "xlargeheight": "765"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/25/magazine/25electroceuticals1/mag-25Electroceuticals-t_CA0-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Brain", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Slaoui, Moncef M", "is_major": "N", "rank": "11", "name": "persons"}, {"value": "Cohen, Adam Ezra", "is_major": "N", "rank": "12", "name": "persons"}, {"value": "Markram, Henry (1962- )", "is_major": "N", "rank": "13", "name": "persons"}, {"value": "Medical Devices", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Biotechnology", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "SetPoint Medical", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "GlaxoSmithKline PLC", "is_major": "Y", "rank": "7", "name": "organizations"}, {"value": "Implants", "is_major": "Y", "rank": "8", "name": "subject"}, {"value": "Tracey, Kevin J", "is_major": "N", "rank": "9", "name": "persons"}, {"value": "Famm, Kristoffer", "is_major": "N", "rank": "10", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michael", "lastname": "BEHAR"}], "original": "By MICHAEL BEHAR"}, "document_type": "article", "pub_date": "2014-05-25T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial", "lead_paragraph": "It will take a concerted effort to ensure that drug treatments are tested in groups that reflect the patients who will be using them.", "headline": {"main": "Gender Imbalance in the Lab", "kicker": "Editorial", "print_headline": "Gender Imbalance in the Lab", "content_kicker": "Editorial"}, "abstract": "Editorial supports National Institutes of Health plan to require drug researchers applying for grants to balance male and female cells and laboratory animals used in studies; holds that move is vital step toward correcting gender imbalance in drug research and addressing vastly different effect that some pharmaceuticals can have on women and men.", "print_page": "20", "word_count": "345", "_id": "537ff31b798810678eb671ba", "snippet": "It will take a concerted effort to ensure that drug treatments are tested in groups that reflect the patients who will be using them.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/24/opinion/gender-imbalance-in-the-lab.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "National Institutes of Health", "is_major": "Y", "rank": "5", "name": "organizations"}, {"value": "Women and Girls", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Editorials", "is_major": "Y", "rank": "7", "name": "subject"}, {"value": "Gender", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [], "original": "By THE EDITORIAL BOARD", "organization": "THE EDITORIAL BOARD"}, "document_type": "article", "pub_date": "2014-05-24T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "OpEd", "lead_paragraph": "Modern antiretroviral drugs could alter the epidemic much as birth control changed the culture in the \u201960s.", "headline": {"main": "Are We Ready for H.I.V.\u2019s Sexual Revolution?", "kicker": "News Analysis", "print_headline": "Are We Ready for H.I.V.\u2019s Sexual Revolution?", "content_kicker": "News Analysis"}, "abstract": "News analysis; decision by Food and Drug Administration to approve drug Truvada for prevention of HIV has triggered backlash among some who believe it will lead to unsafe sex among gay men and increase rates of other sexually transmitted diseases; if preventive use of drug does become accepted, it will show that modern antiretroviral drugs are phenomenally potent weapons that could be key to finally shrinking the epidemic.", "print_page": "6", "word_count": "1208", "_id": "537f2b3c79881021c85e0882", "snippet": "Modern antiretroviral drugs could alter the epidemic much as birth control changed the culture in the \u201960s.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/24/opinion/sunday/ready-for-hivs-sexual-revolution.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Autoimmune Diseases", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Truvada (Drug)", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2014-05-24T00:00:00Z", "section_name": "Sunday Review"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Millions of Americans have Type 2 diabetes, and drug and device companies are racing to tap into the multibillion-dollar market, adding confusion and raising costs.", "headline": {"main": "Type 2 Diabetics Face a Flood of Drugs and Tests", "kicker": "Paying Till It Hurts", "print_headline": "Type 2 Diabetics Face a Flood of Drugs and Tests ", "content_kicker": "Paying Till It Hurts"}, "abstract": null, "print_page": "", "word_count": "1343", "_id": "537e4d1179881021c85e0601", "snippet": "Millions of Americans have Type 2 diabetes, and drug and device companies are racing to tap into the multibillion-dollar market, adding confusion and raising costs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/22/us/type-2-diabetics-face-a-flood-of-drugs-and-tests.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/21/us/21DIABETES3/21DIABETES3-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/21/us/21DIABETES3/21DIABETES3-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/21/us/21DIABETES3/21DIABETES3-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/21/us/21DIABETES3/21DIABETES3-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/21/us/21DIABETES3/21DIABETES3-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/21/us/21DIABETES3/21DIABETES3-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Diabetes", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elisabeth", "lastname": "ROSENTHAL"}], "original": "By ELISABETH ROSENTHAL"}, "document_type": "article", "pub_date": "2014-05-22T00:00:00Z", "section_name": "U.S."}], "meta": {"hits": 8, "offset": 0, "time": 54}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}